Clinical Trial Update: Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction [NA]

View source ↗

Summary

A trial of Saccharomyces cerevisiae CNCM I-3856 for irritable bowel syndrome with diarrhea and post-infectious bowel dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea
• Post-infectious Bowel Dysfunction

Drugs mentioned

• Saccharomyces cerevisiae CNCM I-3856 (Saccharomyces cerevisiae CNCM I-3856)

Snippet

Sponsor: University of Nottingham | Conditions: Irritable Bowel Syndrome, Post Infective Bowel Dysfunction | NA | Status: WITHDRAWN